APA

Ramakers-van Woerden N. L., Beverloo H. B., Veerman A. J. P., Camitta B. M., Loonen A. H., van Wering E. R., Slater R. M., Harbott J., den Boer M. L., Ludwig W. D., Haas O. A., Janka-Schaub G. E. & Pieters R. (20040324). In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype. : Leukemia.

Chicago

Ramakers-van Woerden N L, Beverloo H B, Veerman A J P, Camitta B M, Loonen A H, van Wering E R, Slater R M, Harbott J, den Boer M L, Ludwig W D, Haas O A, Janka-Schaub G E and Pieters R. 20040324. In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype. : Leukemia.

Harvard

Ramakers-van Woerden N. L., Beverloo H. B., Veerman A. J. P., Camitta B. M., Loonen A. H., van Wering E. R., Slater R. M., Harbott J., den Boer M. L., Ludwig W. D., Haas O. A., Janka-Schaub G. E. and Pieters R. (20040324). In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype. : Leukemia.

MLA

Ramakers-van Woerden N L, Beverloo H B, Veerman A J P, Camitta B M, Loonen A H, van Wering E R, Slater R M, Harbott J, den Boer M L, Ludwig W D, Haas O A, Janka-Schaub G E and Pieters R. In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype. : Leukemia. 20040324.